Company: CRVO
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001437749-25-013543
Chunk: 1

Company: CervoMed Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 1
---
, seven persons will be elected to our Board of Directors. In addition, we will ask stockholders to ratify the appointment of RSM US LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025, approve, on an advisory basis, the compensation of our named executive officers during the year ended December 31, 2024, and approve the CervoMed Inc. 2025 Equity Incentive Plan. Such other business will be transacted as may properly come before the Annual Meeting.

On behalf of the Board of Directors and management of CervoMed Inc., it is my pleasure to express our appreciation for your support.

Sincerely,

/s/ John Alam, M.D.

John Alam, M.D.
President & Chief Executive Officer

Your vote is important. Please exercise your right to vote as soon as possible by completing, signing, dating, and returning your proxy card, by using Internet or telephone voting as described in the accompanying proxy statement, or by following the other instructions for voting on the accompanying Notice Regarding the Availability of Proxy Materials.

You can help us make a difference by eliminating paper proxy mailings. With your consent, we will provide all future proxy materials electronically. Instructions for consenting to electronic delivery can be found on your proxy card. Your consent to receive stockholder materials electronically will remain in effect until canceled.

<div align='center'>20 PARK PLAZA, SUITE 424

BOSTON, MA 02116

NOTICE OF 2025 ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON FRIDAY, JUNE 23, 2025</div>

To the Stockholders of CervoMed Inc.:

The 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of CervoMed Inc., a Delaware corporation, will be held virtually on Monday, June 23, 2025, at 9:00 a.m. Eastern Time by means of a live webcast for the following purposes:

| 1. | To elect seven persons to serve as directors until our next annual meeting of stockholders or until their respective successors are elected and qualified; |

| 4. | To approve the CervoMed Inc. 2025 Equity Incentive Plan; and |

| 5. | To transact such other business as may properly come before the meeting or any adjournment of the meeting. |

You will be able to submit questions in advance of the meeting, listen to the meeting